Pyxis Oncology annual free cash flow
2020
2021
2022
2023
2024
2025
Pyxis Oncology Free Cash Flow (FCF) History (PYXS)
Pyxis Oncology reported −$63.5M in free cash flow for fiscal 2025, a decrease of $5.6M from the previous fiscal year, with a free cash flow margin of −458.30%.
View full Pyxis Oncology company overviewPyxis Oncology free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$63.5M | −$5.6M | — | −458.30% |
| 2024 | 2024-12-31 | −$57.9M | $19.5M | — | −358.66% |
| 2023 | 2023-12-31 | −$77.4M | $18.3M | — | — |
| 2022 | 2022-12-31 | −$95.7M | −$59.9M | — | — |
| 2021 | 2021-12-31 | −$35.9M | −$24.3M | — | — |
| 2020 | 2020-12-31 | −$11.6M | — | — | — |
Pyxis Oncology quarterly free cash flow
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | −$19.3M | −$4.0M | — | — |
| Q3 2024 | 2024-09-30 | −$14.7M | $3.0M | — | — |
| Q2 2024 | 2024-06-30 | −$3.0M | $10.3M | — | — |
| Q1 2024 | 2024-03-31 | −$20.9M | $10.3M | — | −129.73% |
| Q4 2023 | 2023-12-31 | −$15.3M | $4.0M | — | — |
| Q3 2023 | 2023-09-30 | −$17.6M | $7.2M | — | — |
| Q2 2023 | 2023-06-30 | −$13.3M | $10.6M | — | — |
| Q1 2023 | 2023-03-31 | −$31.2M | −$3.4M | — | — |
| Q4 2022 | 2022-12-31 | −$19.2M | −$7.1M | — | — |
| Q3 2022 | 2022-09-30 | −$24.8M | −$17.5M | — | — |
| Q2 2022 | 2022-06-30 | −$23.8M | −$26.3M | — | — |
| Q1 2022 | 2022-03-31 | −$27.8M | −$8.9M | — | — |
| Q4 2021 | 2021-12-31 | −$12.2M | — | — | — |
| Q3 2021 | 2021-09-30 | −$7.3M | — | — | — |
| Q2 2021 | 2021-06-30 | $2.5M | — | — | — |
| Q1 2021 | 2021-03-31 | −$18.9M | — | — | — |
Pyxis Oncology free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$11.6M to −$63.5M, a net decrease of $51.9M. Pyxis Oncology's latest reported quarter, Q4 2024, generated −$19.3M in free cash flow, a decrease of $4.0M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Pyxis Oncology filings at SEC.gov ↗